
Penumbra, Inc. – NYSE:PEN
Penumbra stock price today
Penumbra stock price monthly change
Penumbra stock price quarterly change
Penumbra stock price yearly change
Penumbra key metrics
Market Cap | 9.22B |
Enterprise value | 11.06B |
P/E | -5733 |
EV/Sales | 13.06 |
EV/EBITDA | 390.38 |
Price/Sales | 12.86 |
Price/Book | 10.91 |
PEG ratio | 42.24 |
EPS | 2.41 |
Revenue | 1.09B |
EBITDA | 125.18M |
Income | 93.39M |
Revenue Q/Q | 15.43% |
Revenue Y/Y | 23.86% |
Profit margin | -0.24% |
Oper. margin | 0.72% |
Gross margin | 63.18% |
EBIT margin | 0.72% |
EBITDA margin | 11.42% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePenumbra stock price history
Penumbra stock forecast
Penumbra financial statements
$237.56
Potential downside: -4.57%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 261.49M | 18.96M | 7.25% |
---|---|---|---|
Sep 2023 | 270.94M | 9.21M | 3.4% |
Dec 2023 | 284.67M | 54.21M | 19.05% |
Mar 2024 | 278.65M | 11.00M | 3.95% |
Jun 2023 | 1432532000 | 365.98M | 25.55% |
---|---|---|---|
Sep 2023 | 1468377000 | 364.23M | 24.81% |
Dec 2023 | 1556305000 | 377.36M | 24.25% |
Mar 2024 | 1579845000 | 376.31M | 23.82% |
Jun 2023 | 17.09M | -6.67M | 8.69M |
---|---|---|---|
Sep 2023 | 30.84M | -44.39M | 212K |
Dec 2023 | 36.26M | 24.28M | 5.92M |
Mar 2024 | 38.29M | 18.38M | -794K |
Penumbra alternative data
Sep 2023 | 3,900 |
---|---|
Oct 2023 | 3,900 |
Nov 2023 | 3,900 |
Dec 2023 | 3,900 |
Jan 2024 | 3,900 |
Feb 2024 | 3,900 |
Mar 2024 | 4,200 |
Apr 2024 | 4,200 |
May 2024 | 4,200 |
Jun 2024 | 4,200 |
Jul 2024 | 4,200 |
Penumbra other data
Period | Buy | Sel |
---|---|---|
Jan 2024 | 0 | 255 |
Mar 2024 | 0 | 8878 |
Apr 2024 | 0 | 770 |
May 2024 | 0 | 15600 |
Jun 2024 | 0 | 600 |
Jul 2024 | 0 | 15770 |
Aug 2024 | 0 | 30600 |
Sep 2024 | 0 | 16382 |
Oct 2024 | 0 | 15936 |
Nov 2024 | 0 | 17398 |
Dec 2024 | 0 | 16254 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | ELSESSER ADAM director, officer.. | Common Stock | 800 | $240.79 | $192,632 | ||
Sale | ELSESSER ADAM director, officer.. | Common Stock | 4,038 | $242.1 | $977,600 | ||
Sale | ELSESSER ADAM director, officer.. | Common Stock | 5,435 | $242.94 | $1,320,379 | ||
Sale | ELSESSER ADAM director, officer.. | Common Stock | 3,698 | $243.91 | $901,979 | ||
Sale | ELSESSER ADAM director, officer.. | Common Stock | 1,029 | $244.75 | $251,848 | ||
Option | SHIU LAMBERT officer: Chief Ac.. | Common Stock | 5,250 | $12.36 | $64,890 | ||
Option | SHIU LAMBERT officer: Chief Ac.. | Stock Option (right to buy) | 5,250 | $12.36 | $64,890 | ||
Sale | ROBERTS JOHANNA officer: EVP, Gen.. | Common Stock | 36 | $242.5 | $8,730 | ||
Sale | ROBERTS JOHANNA officer: EVP, Gen.. | Common Stock | 106 | $243.24 | $25,783 | ||
Sale | ROBERTS JOHANNA officer: EVP, Gen.. | Common Stock | 177 | $244.61 | $43,296 |
Patent |
---|
Application Filling date: 4 Mar 2022 Issue date: 8 Sep 2022 |
Grant Filling date: 7 Apr 2021 Issue date: 6 Sep 2022 |
Grant Filling date: 5 Jun 2018 Issue date: 6 Sep 2022 |
Grant Filling date: 22 Feb 2019 Issue date: 30 Aug 2022 |
Grant Filling date: 10 Dec 2018 Issue date: 2 Aug 2022 |
Grant Filling date: 30 Jun 2020 Issue date: 19 Jul 2022 |
Grant Filling date: 27 Jun 2019 Issue date: 19 Jul 2022 |
Grant Filling date: 28 Jul 2021 Issue date: 24 May 2022 |
Application Filling date: 6 Dec 2021 Issue date: 24 Mar 2022 |
Application Filling date: 22 Jul 2021 Issue date: 3 Feb 2022 |
Quarter | Transcript |
---|---|
Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 22 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 1 Aug 2023 | Q2 2023 Earnings Call Transcript |
Penumbra: AI Meets Aspiration - Why The Stock Is A Structural Winner
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
A Leaner AngioDynamics Is A High-Risk Execution-Driven Story
Penumbra: Appeal Improves, Just Not Appealing Yet
Penumbra: Impressive, But Running A Bit Hot
Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors
Penumbra: Deep Dive Answering Key Investment Questions
Penumbra: Today's Best Medical Equipment Nearby Cap-Gain Buy
Sector Rerating Has Cast A Shadow Over Penumbra
-
What's the price of Penumbra stock today?
One share of Penumbra stock can currently be purchased for approximately $248.94.
-
When is Penumbra's next earnings date?
Unfortunately, Penumbra's (PEN) next earnings date is currently unknown.
-
Does Penumbra pay dividends?
No, Penumbra does not pay dividends.
-
How much money does Penumbra make?
Penumbra has a market capitalization of 9.22B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.95% to 1.06B US dollars.
-
What is Penumbra's stock symbol?
Penumbra, Inc. is traded on the NYSE under the ticker symbol "PEN".
-
What is Penumbra's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Penumbra?
Shares of Penumbra can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Penumbra's key executives?
Penumbra's management team includes the following people:
- Ms. Maggie S. Yuen Chief Financial Officer(age: 53, pay: $519,040)
- Ms. Johanna Roberts Executive Vice President, Gen. Counsel & Sec.(age: 53, pay: $441,930)
- Mr. Lambert Shiu Chief Accounting Officer(age: 45, pay: $413,210)
- Mr. Adam Elsesser Co-Founder, Chairman, Pres & Chief Executive Officer(age: 63, pay: $219,030)
-
Is Penumbra founder-led company?
Yes, Penumbra is a company led by its founder Mr. Adam Elsesser.
-
How many employees does Penumbra have?
As Jul 2024, Penumbra employs 4,200 workers.
-
When Penumbra went public?
Penumbra, Inc. is publicly traded company for more then 9 years since IPO on 18 Sep 2015.
-
What is Penumbra's official website?
The official website for Penumbra is penumbrainc.com.
-
Where are Penumbra's headquarters?
Penumbra is headquartered at One Penumbra Place, Alameda, CA.
-
How can i contact Penumbra?
Penumbra's mailing address is One Penumbra Place, Alameda, CA and company can be reached via phone at +51 07483200.
-
What is Penumbra stock forecast & price target?
Based on 8 Wall Street analysts` predicted price targets for Penumbra in the last 12 months, the avarage price target is $237.56. The average price target represents a -4.57% change from the last price of $248.94.
Penumbra company profile:

Penumbra, Inc.
penumbrainc.comNYSE
4,200
Medical - Devices
Healthcare
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Alameda, CA 94502
CIK: 0001321732
ISIN: US70975L1070
CUSIP: 70975L107